K+ channel expression in human breast cancer cells:: Involvement in cell cycle regulation and carcinogenesis

被引:114
|
作者
Ouadid-Ahidouch, Halima [1 ]
Ahidouch, Ahmed [1 ,2 ]
机构
[1] Univ Picardie Jules Verne, Lab Physiol Cellulaire & Mol, Fac Sci, F-80039 Amiens, France
[2] Univ Ibn Zohr, Physiol Anim Lab, Fac Sci, Agadir 80000, Morocco
来源
JOURNAL OF MEMBRANE BIOLOGY | 2008年 / 221卷 / 01期
关键词
K+ channel; breast cancer cell; cell cycle progression; membrane hyperpolarization;
D O I
10.1007/s00232-007-9080-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
K+ channels are a most diverse class of ion channels in the plasma membrane and are distributed widely throughout a variety of cells including cancer cells. Evidence has been accumulating from fundamental studies indicating that tumour cells possess various types of K+ channels and that these K+ channels play important roles in regulating tumor cell proliferation, cell cycle progression and apoptosis. Moreover, a significant increase in K+ channel expression has been correlated with tumorigenesis, suggesting the possibility of using these proteins as transformation markers and perhaps reducing the tumor growth rate by selectively inhibiting their functional activity. Significant progress has been made in defining the properties of breast K+ channels, including their biophysical and pharmacological properties and distribution throughout different phases of the cell cycle in breast cell line MCF-7. This review aims to provide a comprehensive overview of the current state of research into K+ channels/currents in breast cancer cells. The possible mechanisms by which K+ channels affect tumor cell proliferation and cell cycle progression are discussed.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Impact of miRNA Sequence on miRNA Expression and Correlation between miRNA Expression and Cell Cycle Regulation in Breast Cancer Cells
    Luo, Zijun
    Zhao, Yi
    Azencott, Robert
    PLOS ONE, 2014, 9 (04):
  • [32] Downregulation of the Ca2+-activated K+ channel K(Ca)3.1 by histone deacetylase inhibition in human breast cancer cells
    Ohya, Susumu
    Kanatsuka, Saki
    Hatano, Noriyuki
    Kito, Hiroaki
    Matsui, Azusa
    Fujimoto, Mayu
    Matsuba, Sayo
    Niwa, Satomi
    Zhan, Peng
    Suzuki, Takayoshi
    Muraki, Katsuhiko
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (02):
  • [33] Swelling-activated taurine and K+ transport in human cervical cancer cells: association with cell cycle progression
    Meng-Ru Shen
    Cheng-Yang Chou
    J. Clive Ellory
    Pflügers Archiv, 2001, 441 : 787 - 795
  • [34] Swelling-activated taurine and K+ transport in human cervical cancer cells:: association with cell cycle progression
    Shen, MR
    Chou, CY
    Ellory, JC
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2001, 441 (06): : 787 - 795
  • [35] KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells
    Arthur, Greer K.
    Duffy, S. Mark
    Roach, Katy M.
    Hirst, Rob A.
    Shikotra, Aarti
    Gaillard, Erol A.
    Bradding, Peter
    PLOS ONE, 2015, 10 (12):
  • [36] K+ channels and cell cycle progression in tumor cells
    Ouadid-Ahidouch, Halima
    Ahidouch, Ahmed
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [37] Expression of K+ channels in normal and cancerous human breast
    Brevet, Marie
    Ahidouch, Ahmed
    Sevestre, Henri
    Merviel, Philippe
    El Hiani, Yassine
    Robbe, Micheline
    Ouadid-Ahidouch, Halima
    HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (08) : 965 - 972
  • [38] β2-Adrenoceptor regulation of the K+ channel iKCa1 in human mast cells
    Duffy, SM
    Cruse, G
    Lawley, WJ
    Bradding, P
    FASEB JOURNAL, 2005, 19 (06): : 1006 - +
  • [39] Regulation of an inwardly rectifying K+ channel by nitric oxide in cultured human proximal tubule cells
    Nakamura, K
    Hirano, J
    Kubokawa, M
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (03) : F411 - F417
  • [40] Cell Cycle Regulation in Treatment of Breast Cancer
    Cai, Zijie
    Liu, Qiang
    TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 251 - 270